Gestational trophoblastic neoplasia surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Surgery is the mainstay of treatment for choriocarcinoma. | Surgery is the mainstay of treatment for choriocarcinoma. | ||
==Surgery== | |||
==Hysterectomy== | ===Hysterectomy=== | ||
Surgery is one of the main treatments for GTD. | Surgery is one of the main treatments for GTD. | ||
* Indication | * Indication | ||
Revision as of 21:11, 15 October 2015
Template:Choriocarcinoma Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]
Overview
Surgery is the mainstay of treatment for choriocarcinoma.
Surgery
Hysterectomy
Surgery is one of the main treatments for GTD.
- Indication
- As the primary treatment for GTD
- Recurrence of GTD after other treatments
Hysterectomy
- Hysterectomy may be offered to women with malignant GTD that has not spread outside of the uterus and who no longer wish to have children.
- Hysterectomy may also be recommended to women with malignant GTD that does not respond to chemotherapy.
- Hysterectomy is the primary treatment for women with placental site trophoblastic tumours because this type of cancer does not respond well to chemotherapy.
Surgery to remove metastases
- Surgery may be done for GTD that has spread to distant sites in the body, such as the brain, intestines, kidney, liver, lungs and spleen.
- In the case of brain metastases, surgery may only be done if a tumor is close to the surface of the brain.